We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Cheap habit

24 November 2008 By Robert Cyran

Numerous tech and biotech companies are valued at less than the net cash on their books. Many of these firms are just trash, but activists and value investors might still be able to get a last puff of value from some of them.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)